130 related articles for article (PubMed ID: 7298795)
1. Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I.
de Deuxchaisnes CN; Fischer JA; Dambacher MA; Devogelaer JP; Arber CE; Zanelli JM; Parsons JA; Loveridge N; Bitensky L; Chayen J
J Clin Endocrinol Metab; 1981 Dec; 53(6):1105-9. PubMed ID: 7298795
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type I.
Loveridge N; Fischer JA; Nagant de Deuxchaisnes C; Dambacher MA; Tschopp F; Werder E; Devogelaer JP; de Meyer R; Bitensky L; Chayen J
J Clin Endocrinol Metab; 1982 Jun; 54(6):1274-5. PubMed ID: 7076801
[TBL] [Abstract][Full Text] [Related]
3. The metatarsal cytochemical bioassay of parathyroid hormone: validation, specificity, and application to the study of pseudohypoparathyroidism type I.
Bradbeer JN; Dunham J; Fischer JA; Nagant de Deuxchaisnes C; Loveridge N
J Clin Endocrinol Metab; 1988 Dec; 67(6):1237-43. PubMed ID: 3192680
[TBL] [Abstract][Full Text] [Related]
4. Suppression of parathyroid hormone inhibitory activity of plasma in pseudohypoparathyroidism type I by i.v. calcium.
Loveridge N; Fischer JA; Devogelaer JP; Nagant de Deuxchaisnes C
Clin Endocrinol (Oxf); 1986 May; 24(5):549-54. PubMed ID: 3791650
[TBL] [Abstract][Full Text] [Related]
5. An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism: comparison with vitamin D deficiency.
Allgrove J; Chayen J; Jayaweera P; O'Riordan JL
Clin Endocrinol (Oxf); 1984 May; 20(5):503-14. PubMed ID: 6744632
[TBL] [Abstract][Full Text] [Related]
6. Examination of circulating parathyroid hormone in pseudohypoparathyroidism.
Mitchell J; Goltzman D
J Clin Endocrinol Metab; 1985 Aug; 61(2):328-34. PubMed ID: 4008609
[TBL] [Abstract][Full Text] [Related]
7. Separation of inhibitory activity from biologically active parathyroid hormone in patients with pseudohypoparathyroidism type I.
Loveridge N; Tschopp F; Born W; Devogelaer JP; Nagant de Deuxchaisnes C; Fischer JA
Biochim Biophys Acta; 1986 Nov; 889(2):117-22. PubMed ID: 3778943
[TBL] [Abstract][Full Text] [Related]
8. An adenylate cyclase bioassay for parathyroid hormone: some clinical experiences.
Seshadri MS; Chan YL; Wilkinson MR; Mason RS; Posen S
Clin Sci (Lond); 1985 Mar; 68(3):321-6. PubMed ID: 3971662
[TBL] [Abstract][Full Text] [Related]
9. Distribution of circulating immunoreactive components of parathyroid hormone in normal subjects and in patients with primary and secondary hyperparathyroidism: the role of the kidney and of the serum calcium concentration.
Dambacher MA; Fischer JA; Hunziker WH; Born W; Moran J; Roth HR; Delvin EE; Glorieux FH
Clin Sci (Lond); 1979 Nov; 57(5):435-43. PubMed ID: 519952
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of a radioimmunoassay for parathyroid hormone in human serum.
Almqvist S; Hjern B; Wästhed B
Acta Endocrinol (Copenh); 1975 Mar; 78(3):493-509. PubMed ID: 1173015
[TBL] [Abstract][Full Text] [Related]
11. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
[TBL] [Abstract][Full Text] [Related]
12. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
[TBL] [Abstract][Full Text] [Related]
13. Ratio of baseline level/maximum level of serum PTH in pseudohypoparathyroidism and primary hyperparathyroidism.
Mizunashi K; Furukawa Y; Goto MM
Calcif Tissue Int; 1998 Feb; 62(2):99-103. PubMed ID: 9437041
[TBL] [Abstract][Full Text] [Related]
14. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism.
Sinha TK; Miller S; Feming J; Khairi R; Edmondson J; Johnston CC; Bell NH
J Clin Endocrinol Metab; 1975 Dec; 41(06):1009-13. PubMed ID: 1239461
[TBL] [Abstract][Full Text] [Related]
16. Renal adenylate cyclase assay for biologically active parathyroid hormone: clinical utility and physiological significance.
Auf'mkolk B; Hesch RD
J Endocrinol; 1986 Jan; 108(1):9-15. PubMed ID: 3944539
[TBL] [Abstract][Full Text] [Related]
17. Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay.
Papapoulos SE; Manning RM; Hendy GN; Lewin IG; O'Riordan JL
Clin Endocrinol (Oxf); 1980 Jul; 13(1):57-67. PubMed ID: 7438464
[TBL] [Abstract][Full Text] [Related]
18. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
Stögmann W
Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
[TBL] [Abstract][Full Text] [Related]
19. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay.
Blind E; Schmidt-Gayk H; Scharla S; Flentje D; Fischer S; Göhring U; Hitzler W
J Clin Endocrinol Metab; 1988 Aug; 67(2):353-60. PubMed ID: 3292561
[TBL] [Abstract][Full Text] [Related]
20. Discordant disappearance of bioactive and immunoreactive parathyroid hormone after parathyroidectomy.
Goltzman D; Gomolin H; DeLean A; Wexler M; Meakins JL
J Clin Endocrinol Metab; 1984 Jan; 58(1):70-5. PubMed ID: 6358244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
